Livin, Survivin and Caspase 3 as early recurrence markers in non-muscle-invasive bladder cancer
- 5 March 2014
- journal article
- Published by Springer Nature in World Journal of Urology
- Vol. 32 (6) , 1477-1484
Abstract
To explore the potential correlation and prognostic value of Livin, Survivin and Caspase 3 expression in non-muscle-invasive bladder cancer (NMIBC). We prospectively examined the simultaneous expression of Livin, Survivin and Caspase 3 with immunohistochemistry in the paraffin blocks of 138 patients who underwent transurethral resection, and ten cases of normal bladder specimens were studied as the control group. During a 48-month follow-up, clinical pathologic factors including gender, age, pathology stage, histology grade, adjuvant therapy and recurrence time were recorded. The curves for recurrence-free survival (RFS) were estimated by the Kaplan–Meier method, and the relationship between these proteins’ expression and clinical pathologic factors was analyzed with the Cox regression model. Livin and Survivin showed a high expression (H-exp) level of 65.22 and 71.01 % in NMIBC, respectively, whereas Caspase 3 expression level was 50.72 %, and H-exp level of Livin and Survivin were 72.7 and 80.0 % in pT1 stage, respectively, which were proved to be higher than that in pTa/Tis ratio (P < 0.05). The relation between the H-exp and low-expression (L-exp) groups of Livin and Survivin and RFS were found statistically significant (P < 0.05). Conversely, there was better RFS in H-exp Caspase 3 group than in L-exp group (P < 0.05). A risk score was developed on the basis of all three biomarkers to estimate the prognosis of NMIBC patients, and those expressing high Survivin and Livin and low Caspase 3 had a significant shorter RFS time (P < 0.05). Livin, Survivin and Caspase 3 may be valuable as promising indicators of early recurrence in NMIBC.Keywords
This publication has 28 references indexed in Scilit:
- Inhibitors of Apoptosis Proteins (IAPs) as Potential Molecular Targets for Therapy of Hematological MalignanciesCurrent Molecular Medicine, 2011
- Antisense oligonucleotide targeting Livin induces apoptosis of human bladder cancer cell via a mechanism involving caspase 3Journal of Experimental & Clinical Cancer Research, 2010
- Therapeutic potential of siRNA-mediated combined knockdown of the IAP genes (Livin, XIAP, and Survivin) on human bladder cancer T24 cellsActa Biochimica et Biophysica Sinica, 2010
- Survivin and Smac Gene Expressions but not Livin Are Predictors of Prognosis in Non-small Cell Lung Cancer Patients Treated with Adjuvant Chemotherapy Following SurgeryJapanese Journal of Clinical Oncology, 2010
- Smac mimetics as new cancer therapeuticsAnti-Cancer Drugs, 2009
- Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatmentUrologic Oncology: Seminars and Original Investigations, 2009
- Survivin: a promising biomarker for detection and prognosis of bladder cancerWorld Journal of Urology, 2007
- Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomyThe Lancet Oncology, 2007
- Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladderLaboratory Investigation, 2006
- Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer.2003